Kevin Cureton - Dec 31, 2024 Form 4 Insider Report for NANOPHASE TECHNOLOGIES Corp (NANX)

Role
Chief Operating Officer
Signature
/s/ Jess Jankowski under UPA for Kevin Cureton
Stock symbol
NANX
Transactions as of
Dec 31, 2024
Transactions value $
$54,900
Form type
4
Date filed
1/13/2025, 05:19 PM
Previous filing
Sep 25, 2024
Next filing
Jun 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NANX Common Stock 192K Dec 31, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NANX Common Stock (right to purchase) Award $54.9K +22.5K $2.44 22.5K Dec 31, 2024 Common Stock 22.5K $2.44 Direct F1
holding NANX Common Stock (right to purchase) 43.5K Dec 31, 2024 Common Stock 43.5K $0.42 Direct F1
holding NANX Common Stock (right to purchase) 50K Dec 31, 2024 Common Stock 50K $0.68 Direct F1
holding NANX Common Stock (right to purchase) 80K Dec 31, 2024 Common Stock 80K $0.82 Direct F1
holding NANX Common Stock (right to purchase) 16.5K Dec 31, 2024 Common Stock 16.5K $0.51 Direct F1
holding NANX Common Stock (right to purchase) 90K Dec 31, 2024 Common Stock 90K $0.45 Direct F1
holding NANX Common Stock (right to purchase) 90K Dec 31, 2024 Common Stock 90K $4.17 Direct F1
holding NANX Common Stock (right to purchase) 72K Dec 31, 2024 Common Stock 72K $1.17 Direct F1
holding NANX Common Stock (right to purchase) 12.6K Dec 31, 2024 Common Stock 12.6K $0.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Remarks:

This report is being filed late due to an administrative error on the part of the Company. Mr. Cureton received this grant of stock options as part of the Company's annual equity compensation practices.